Research Peptide
TrimeraTirzepatide (GLP2-T)
$119.99
· Synthetic · Manufactured
1
Purity
99%+
Concentration
30mg
Molecular Weight
4813 g/mol
CAS Number
—
Research Profile
Tirzepatide (GLP2-T) — Mechanism of Action
The following is drawn from preclinical research literature and is provided for informational purposes only. It does not constitute medical advice or imply therapeutic outcomes.
- —Detailed mechanism of action data is being compiled for this compound.
Chemical Identification
Compound Properties
TypePeptide / Synthetic
MW4813 g/mol
Research Journal
Related reading
How to Reconstitute Lyophilized Peptides: Solvents, Ratios, and Storage
Lyophilized peptides have to go back into solution before they can be used, and the choices made at that step — solvent, volume, technique, storage — determine whether the material survives intact. A practical guide to each decision and the chemistry behind it.
Read article →Retatrutide vs. Tirzepatide: Receptor Targets, Structure, and the Published Literature
Tirzepatide engages two receptors; retatrutide engages three. A comparison at the level of receptor pharmacology, molecular structure, and what the peer-reviewed clinical literature actually reports for each.
Read article →How to Read a Peptide Certificate of Analysis: HPLC, Mass Spec, and What Purity Actually Means
Purity, identity, and content are three separate questions answered by three separate tests. A guide to reading each section of a peptide COA, and to the number that is missing more often than not.
Read article →
Laboratory Standards
The Precision of Synthesis
Our Trimera is synthesized via solid-phase methodology, ensuring the highest degree of structural integrity. Every sequence is scrutinized against theoretical models to guarantee exact molecular match.
Each batch undergoes a full HPLC purity analysis and mass spectrometry confirmation before release.
Complementary Sequences
Recommended for targeted decreases in protocols.
CGMP Compliant
Exclusive Service
CLIA Qualified
Clinical Precision